Madeline King, PharmD, BCIDP is an infectious diseases PGY2 residency program director, and outpatient infectious diseases clinical pharmacist, Cooper University Hospital.
Antimicrobial Prescribing in the Telehealth Setting: Framework for Stewardship During a Period of Rapid Acceleration Within Primary Care
Telemedicine use is likely to continue expanding even as the COVID-19 pandemic slowly resolves.
Influenza Vaccination With SARS-CoV-2 mRNA Booster Shots
Drs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.
CDC and FDA Recommendations for SARS-CoV-2 Booster Shots
Experts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.
Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Jacinda Abdul-Mutakabbir, PharmD; and Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; review what encompasses a bivalent vaccine and give their perspective on how to communicate the role of the vaccine in optimizing protection for patients.
Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations
Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, leads a discussion on the constant evolution of SARS-CoV-2 variants and the impact on vaccine and booster shot development and administration.
COVID-19 Booster Vaccination Protection Rates
Jacinda Abdul-Mutakabbir, PharmD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; and Madeline King, PharmD, BCIDP, examine the efficacy and real-world implications of the COVID-19 booster shot in terms of vaccination protection rates.
Impact of SARS-CoV-2 Subvariants on Vaccination
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, leads a discussion on the challenges subvariants of SARS-CoV-2 present in terms of vaccination and approaching optimal communication to the public surrounding vaccination.
Defining Variants of Interest vs Variants of Concern
Expert health professionals share their thoughts on variants of concern vs variants of interest of the SARS-CoV-2 strains as they relate to clinical practice.
Overview of SARS-CoV-2 Virus and Subvariants
Jacinda Abdul-Mutakabbir, PharmD, discusses the difference between the original SARS-CoV-2 strain and subvariant strains.
Rickettsial Infections Heat Up in the US
With the warmer months in full swing, here are clinical considerations
and strategies for tick-borne infections.
Assisting With International Health Care Needs
Although the pandemic halted many medical mission assignments, these opportunities and others are becoming available to help those geographic areas with acute needs.
New Recommendations for Antibiotic Prophylaxis Prior to Dental Procedures
The American Dental Association (ADA) has updated patient profiles on who should be indicated for antibiotic prophylaxis.
2 Clarke Drive Cranbury, NJ 08512